GlassScriptPhysician profile
Anna Kapsalis-Rambalakos
NPI 1093985574
$2,124.88
in general payments reported to CMS, 2019-2025
17 companies · $501 in 2025
The $501 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $944 · 2020: $171 · 2023: $268 · 2024: $241 · 2025: $501.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,009.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,009.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $435.00 | 2019-2025 | Farxiga, Breztri |
| Amgen INC. | $270.43 | 2019 | |
| Novo Nordisk INC | $270.36 | 2019-2025 | Wegovy |
| Merck Sharp & Dohme LLC | $188.04 | 2019 | |
| Apollo Endosurgery US INC | $149.20 | 2023 | Overstitch Endoscopic Suturing System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $147.15 | 2019 | |
| Abbvie INC. | $123.83 | 2024 | |
| Enterra Medical, INC. | $116.92 | 2024 | |
| Sumitomo Pharma America, INC. | $99.87 | 2025 | Gemtesa |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $98.53 | 2019 | |
| Amarin Pharma, INC. | $65.87 | 2019-2020 | |
| Pfizer INC. | $53.66 | 2019-2020 | |
| Lilly USA, LLC | $42.56 | 2019-2025 | Zepbound, Mounjaro |
| Kowa Pharmaceuticals America, INC. | $24.06 | 2019 | |
| Glaxosmithkline, LLC. | $15.74 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $11.85 | 2019 | |
| Sanofi Pasteur INC. | $11.81 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Kapsalis-Rambalakos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.